Loading…

MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells

Abstract Clear cell renal cell carcinoma (ccRCC) is the major and aggressive subtype of RCC. Previously, we identified 383 differentially expressed genes by analyzing full-length cDNA libraries of ccRCC and normal kidney tissues. In this study, we applied functional network analysis to the different...

Full description

Saved in:
Bibliographic Details
Published in:Cancer letters 2009-01, Vol.273 (1), p.35-43
Main Authors: Tang, Sai-Wen, Chang, Wen-Hsin, Su, Yih-Ching, Chen, Yu-Chi, Lai, Yen-Han, Wu, Pei-Tzu, Hsu, Chyong-Ing, Lin, Wei-Chou, Lai, Ming-Kuen, Lin, Jung-Yaw
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633
cites cdi_FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633
container_end_page 43
container_issue 1
container_start_page 35
container_title Cancer letters
container_volume 273
creator Tang, Sai-Wen
Chang, Wen-Hsin
Su, Yih-Ching
Chen, Yu-Chi
Lai, Yen-Han
Wu, Pei-Tzu
Hsu, Chyong-Ing
Lin, Wei-Chou
Lai, Ming-Kuen
Lin, Jung-Yaw
description Abstract Clear cell renal cell carcinoma (ccRCC) is the major and aggressive subtype of RCC. Previously, we identified 383 differentially expressed genes by analyzing full-length cDNA libraries of ccRCC and normal kidney tissues. In this study, we applied functional network analysis to the differentially expressed genes for identifying deregulated molecular pathways in ccRCC, and the results indicated that MYC showed a prominent role in the highest scoring network. The upregulation of MYC expression was validated in ccRCC tissues and cell lines. Furthermore, Knockdown of MYC expression by MYC -specific siRNA significantly inhibited the abilities of uncontrolled proliferation, anchorage-independent growth and arrested cell cycle in the G0/G1 phase in ccRCC cells. Moreover, we found that 37 differentially expressed genes were shown to be MYC-target genes, and the upregulation of the MYC-target genes BCL2 , CCND1 , PCNA , PGK1 , and VEGFA were demonstrated. The expression of these MYC-target genes was significantly correlated with the expression of MYC in ccRCC tissues, and knockdown of MYC also suppressed the expression of these MYC-target genes in ccRCC cells. The recruitment of MYC to the promoter regions of BCL2 , CCND1 , PCNA , PGK1 , and VEGFA was shown by Chromatin immunoprecipitation assay. These results suggest that MYC pathway is activated and plays an essential role in the proliferation of ccRCC cells.
doi_str_mv 10.1016/j.canlet.2008.07.038
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66727424</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383508005831</els_id><sourcerecordid>66727424</sourcerecordid><originalsourceid>FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633</originalsourceid><addsrcrecordid>eNqFUk2r1DAUDaL4xtF_IBIQ3LXeNE2abgQZnh_wxIW6cBVu01vM2EnHpPNk9v5wUzrw4G3eKgk59-TknMPYSwGlAKHf7kuHYaS5rABMCU0J0jxiG2GaqmhaA4_ZBiTUhTRSXbFnKe0BQNWNesquhDHQVrXcsH9ffu74Eedff_HMfeLoZn-LM_XcB-5GwsgdjSOPFHBctw6j82E6IMfQc0qJwuzz5TBFfozT6AeKOPsp8Gl4kGI5pufsyYBjoheXdct-fLj-vvtU3Hz9-Hn3_qZwCtq5wA61atBQKwwoMHWnejm0UrVdpXpUQje6qzVI6bqq7qAVg6y16rueOglayi17s_JmmX9OlGZ78GlRgIGmU7JaN1VTZ1-27PU94H46xSw_WaEWE41uq4yqV5SLU0qRBnuM_oDxbAXYJSO7t2tGdsnIQmNzRnns1YX81B2ovxu6hJIB71YAZS9uPUWbnKfgqPeR3Gz7yT_0wn0CN_rgHY6_6Uzp7i82VRbst6UnS03A5IYYKeR_xYq5WA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1505478692</pqid></control><display><type>article</type><title>MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells</title><source>ScienceDirect Journals</source><creator>Tang, Sai-Wen ; Chang, Wen-Hsin ; Su, Yih-Ching ; Chen, Yu-Chi ; Lai, Yen-Han ; Wu, Pei-Tzu ; Hsu, Chyong-Ing ; Lin, Wei-Chou ; Lai, Ming-Kuen ; Lin, Jung-Yaw</creator><creatorcontrib>Tang, Sai-Wen ; Chang, Wen-Hsin ; Su, Yih-Ching ; Chen, Yu-Chi ; Lai, Yen-Han ; Wu, Pei-Tzu ; Hsu, Chyong-Ing ; Lin, Wei-Chou ; Lai, Ming-Kuen ; Lin, Jung-Yaw</creatorcontrib><description>Abstract Clear cell renal cell carcinoma (ccRCC) is the major and aggressive subtype of RCC. Previously, we identified 383 differentially expressed genes by analyzing full-length cDNA libraries of ccRCC and normal kidney tissues. In this study, we applied functional network analysis to the differentially expressed genes for identifying deregulated molecular pathways in ccRCC, and the results indicated that MYC showed a prominent role in the highest scoring network. The upregulation of MYC expression was validated in ccRCC tissues and cell lines. Furthermore, Knockdown of MYC expression by MYC -specific siRNA significantly inhibited the abilities of uncontrolled proliferation, anchorage-independent growth and arrested cell cycle in the G0/G1 phase in ccRCC cells. Moreover, we found that 37 differentially expressed genes were shown to be MYC-target genes, and the upregulation of the MYC-target genes BCL2 , CCND1 , PCNA , PGK1 , and VEGFA were demonstrated. The expression of these MYC-target genes was significantly correlated with the expression of MYC in ccRCC tissues, and knockdown of MYC also suppressed the expression of these MYC-target genes in ccRCC cells. The recruitment of MYC to the promoter regions of BCL2 , CCND1 , PCNA , PGK1 , and VEGFA was shown by Chromatin immunoprecipitation assay. These results suggest that MYC pathway is activated and plays an essential role in the proliferation of ccRCC cells.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2008.07.038</identifier><identifier>PMID: 18809243</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Activation of MYC pathway ; Angiogenesis ; Apoptosis ; Blotting, Western ; Cancer ; Carcinoma, Renal Cell - genetics ; Carcinoma, Renal Cell - metabolism ; Carcinoma, Renal Cell - physiopathology ; Cell culture ; Cell cycle ; Cell Line, Tumor ; Cell Proliferation ; Clear cell renal cell carcinoma ; Full-length cDNA library ; Gene expression ; Gene Expression Regulation, Neoplastic ; Hematology, Oncology and Palliative Medicine ; Humans ; Immunohistochemistry ; Kidney Neoplasms - genetics ; Kidney Neoplasms - metabolism ; Kidney Neoplasms - physiopathology ; Kinases ; Knockdown of MYC ; Lymphoma ; Medical prognosis ; Phase transitions ; Proto-Oncogene Proteins c-myc - genetics ; Proto-Oncogene Proteins c-myc - metabolism ; Reproductive system ; Reverse Transcriptase Polymerase Chain Reaction ; RNA Interference ; RNA polymerase ; Rodents ; Signal Transduction ; Up-Regulation ; Vascular endothelial growth factor</subject><ispartof>Cancer letters, 2009-01, Vol.273 (1), p.35-43</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2008 Elsevier Ireland Ltd</rights><rights>Copyright Elsevier Limited Jan 8, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633</citedby><cites>FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18809243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tang, Sai-Wen</creatorcontrib><creatorcontrib>Chang, Wen-Hsin</creatorcontrib><creatorcontrib>Su, Yih-Ching</creatorcontrib><creatorcontrib>Chen, Yu-Chi</creatorcontrib><creatorcontrib>Lai, Yen-Han</creatorcontrib><creatorcontrib>Wu, Pei-Tzu</creatorcontrib><creatorcontrib>Hsu, Chyong-Ing</creatorcontrib><creatorcontrib>Lin, Wei-Chou</creatorcontrib><creatorcontrib>Lai, Ming-Kuen</creatorcontrib><creatorcontrib>Lin, Jung-Yaw</creatorcontrib><title>MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Abstract Clear cell renal cell carcinoma (ccRCC) is the major and aggressive subtype of RCC. Previously, we identified 383 differentially expressed genes by analyzing full-length cDNA libraries of ccRCC and normal kidney tissues. In this study, we applied functional network analysis to the differentially expressed genes for identifying deregulated molecular pathways in ccRCC, and the results indicated that MYC showed a prominent role in the highest scoring network. The upregulation of MYC expression was validated in ccRCC tissues and cell lines. Furthermore, Knockdown of MYC expression by MYC -specific siRNA significantly inhibited the abilities of uncontrolled proliferation, anchorage-independent growth and arrested cell cycle in the G0/G1 phase in ccRCC cells. Moreover, we found that 37 differentially expressed genes were shown to be MYC-target genes, and the upregulation of the MYC-target genes BCL2 , CCND1 , PCNA , PGK1 , and VEGFA were demonstrated. The expression of these MYC-target genes was significantly correlated with the expression of MYC in ccRCC tissues, and knockdown of MYC also suppressed the expression of these MYC-target genes in ccRCC cells. The recruitment of MYC to the promoter regions of BCL2 , CCND1 , PCNA , PGK1 , and VEGFA was shown by Chromatin immunoprecipitation assay. These results suggest that MYC pathway is activated and plays an essential role in the proliferation of ccRCC cells.</description><subject>Activation of MYC pathway</subject><subject>Angiogenesis</subject><subject>Apoptosis</subject><subject>Blotting, Western</subject><subject>Cancer</subject><subject>Carcinoma, Renal Cell - genetics</subject><subject>Carcinoma, Renal Cell - metabolism</subject><subject>Carcinoma, Renal Cell - physiopathology</subject><subject>Cell culture</subject><subject>Cell cycle</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Clear cell renal cell carcinoma</subject><subject>Full-length cDNA library</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Kidney Neoplasms - genetics</subject><subject>Kidney Neoplasms - metabolism</subject><subject>Kidney Neoplasms - physiopathology</subject><subject>Kinases</subject><subject>Knockdown of MYC</subject><subject>Lymphoma</subject><subject>Medical prognosis</subject><subject>Phase transitions</subject><subject>Proto-Oncogene Proteins c-myc - genetics</subject><subject>Proto-Oncogene Proteins c-myc - metabolism</subject><subject>Reproductive system</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA Interference</subject><subject>RNA polymerase</subject><subject>Rodents</subject><subject>Signal Transduction</subject><subject>Up-Regulation</subject><subject>Vascular endothelial growth factor</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFUk2r1DAUDaL4xtF_IBIQ3LXeNE2abgQZnh_wxIW6cBVu01vM2EnHpPNk9v5wUzrw4G3eKgk59-TknMPYSwGlAKHf7kuHYaS5rABMCU0J0jxiG2GaqmhaA4_ZBiTUhTRSXbFnKe0BQNWNesquhDHQVrXcsH9ffu74Eedff_HMfeLoZn-LM_XcB-5GwsgdjSOPFHBctw6j82E6IMfQc0qJwuzz5TBFfozT6AeKOPsp8Gl4kGI5pufsyYBjoheXdct-fLj-vvtU3Hz9-Hn3_qZwCtq5wA61atBQKwwoMHWnejm0UrVdpXpUQje6qzVI6bqq7qAVg6y16rueOglayi17s_JmmX9OlGZ78GlRgIGmU7JaN1VTZ1-27PU94H46xSw_WaEWE41uq4yqV5SLU0qRBnuM_oDxbAXYJSO7t2tGdsnIQmNzRnns1YX81B2ovxu6hJIB71YAZS9uPUWbnKfgqPeR3Gz7yT_0wn0CN_rgHY6_6Uzp7i82VRbst6UnS03A5IYYKeR_xYq5WA</recordid><startdate>20090108</startdate><enddate>20090108</enddate><creator>Tang, Sai-Wen</creator><creator>Chang, Wen-Hsin</creator><creator>Su, Yih-Ching</creator><creator>Chen, Yu-Chi</creator><creator>Lai, Yen-Han</creator><creator>Wu, Pei-Tzu</creator><creator>Hsu, Chyong-Ing</creator><creator>Lin, Wei-Chou</creator><creator>Lai, Ming-Kuen</creator><creator>Lin, Jung-Yaw</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20090108</creationdate><title>MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells</title><author>Tang, Sai-Wen ; Chang, Wen-Hsin ; Su, Yih-Ching ; Chen, Yu-Chi ; Lai, Yen-Han ; Wu, Pei-Tzu ; Hsu, Chyong-Ing ; Lin, Wei-Chou ; Lai, Ming-Kuen ; Lin, Jung-Yaw</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Activation of MYC pathway</topic><topic>Angiogenesis</topic><topic>Apoptosis</topic><topic>Blotting, Western</topic><topic>Cancer</topic><topic>Carcinoma, Renal Cell - genetics</topic><topic>Carcinoma, Renal Cell - metabolism</topic><topic>Carcinoma, Renal Cell - physiopathology</topic><topic>Cell culture</topic><topic>Cell cycle</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Clear cell renal cell carcinoma</topic><topic>Full-length cDNA library</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Kidney Neoplasms - genetics</topic><topic>Kidney Neoplasms - metabolism</topic><topic>Kidney Neoplasms - physiopathology</topic><topic>Kinases</topic><topic>Knockdown of MYC</topic><topic>Lymphoma</topic><topic>Medical prognosis</topic><topic>Phase transitions</topic><topic>Proto-Oncogene Proteins c-myc - genetics</topic><topic>Proto-Oncogene Proteins c-myc - metabolism</topic><topic>Reproductive system</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA Interference</topic><topic>RNA polymerase</topic><topic>Rodents</topic><topic>Signal Transduction</topic><topic>Up-Regulation</topic><topic>Vascular endothelial growth factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tang, Sai-Wen</creatorcontrib><creatorcontrib>Chang, Wen-Hsin</creatorcontrib><creatorcontrib>Su, Yih-Ching</creatorcontrib><creatorcontrib>Chen, Yu-Chi</creatorcontrib><creatorcontrib>Lai, Yen-Han</creatorcontrib><creatorcontrib>Wu, Pei-Tzu</creatorcontrib><creatorcontrib>Hsu, Chyong-Ing</creatorcontrib><creatorcontrib>Lin, Wei-Chou</creatorcontrib><creatorcontrib>Lai, Ming-Kuen</creatorcontrib><creatorcontrib>Lin, Jung-Yaw</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Sai-Wen</au><au>Chang, Wen-Hsin</au><au>Su, Yih-Ching</au><au>Chen, Yu-Chi</au><au>Lai, Yen-Han</au><au>Wu, Pei-Tzu</au><au>Hsu, Chyong-Ing</au><au>Lin, Wei-Chou</au><au>Lai, Ming-Kuen</au><au>Lin, Jung-Yaw</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2009-01-08</date><risdate>2009</risdate><volume>273</volume><issue>1</issue><spage>35</spage><epage>43</epage><pages>35-43</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Abstract Clear cell renal cell carcinoma (ccRCC) is the major and aggressive subtype of RCC. Previously, we identified 383 differentially expressed genes by analyzing full-length cDNA libraries of ccRCC and normal kidney tissues. In this study, we applied functional network analysis to the differentially expressed genes for identifying deregulated molecular pathways in ccRCC, and the results indicated that MYC showed a prominent role in the highest scoring network. The upregulation of MYC expression was validated in ccRCC tissues and cell lines. Furthermore, Knockdown of MYC expression by MYC -specific siRNA significantly inhibited the abilities of uncontrolled proliferation, anchorage-independent growth and arrested cell cycle in the G0/G1 phase in ccRCC cells. Moreover, we found that 37 differentially expressed genes were shown to be MYC-target genes, and the upregulation of the MYC-target genes BCL2 , CCND1 , PCNA , PGK1 , and VEGFA were demonstrated. The expression of these MYC-target genes was significantly correlated with the expression of MYC in ccRCC tissues, and knockdown of MYC also suppressed the expression of these MYC-target genes in ccRCC cells. The recruitment of MYC to the promoter regions of BCL2 , CCND1 , PCNA , PGK1 , and VEGFA was shown by Chromatin immunoprecipitation assay. These results suggest that MYC pathway is activated and plays an essential role in the proliferation of ccRCC cells.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>18809243</pmid><doi>10.1016/j.canlet.2008.07.038</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2009-01, Vol.273 (1), p.35-43
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_66727424
source ScienceDirect Journals
subjects Activation of MYC pathway
Angiogenesis
Apoptosis
Blotting, Western
Cancer
Carcinoma, Renal Cell - genetics
Carcinoma, Renal Cell - metabolism
Carcinoma, Renal Cell - physiopathology
Cell culture
Cell cycle
Cell Line, Tumor
Cell Proliferation
Clear cell renal cell carcinoma
Full-length cDNA library
Gene expression
Gene Expression Regulation, Neoplastic
Hematology, Oncology and Palliative Medicine
Humans
Immunohistochemistry
Kidney Neoplasms - genetics
Kidney Neoplasms - metabolism
Kidney Neoplasms - physiopathology
Kinases
Knockdown of MYC
Lymphoma
Medical prognosis
Phase transitions
Proto-Oncogene Proteins c-myc - genetics
Proto-Oncogene Proteins c-myc - metabolism
Reproductive system
Reverse Transcriptase Polymerase Chain Reaction
RNA Interference
RNA polymerase
Rodents
Signal Transduction
Up-Regulation
Vascular endothelial growth factor
title MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A24%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MYC%20pathway%20is%20activated%20in%20clear%20cell%20renal%20cell%20carcinoma%20and%20essential%20for%20proliferation%20of%20clear%20cell%20renal%20cell%20carcinoma%20cells&rft.jtitle=Cancer%20letters&rft.au=Tang,%20Sai-Wen&rft.date=2009-01-08&rft.volume=273&rft.issue=1&rft.spage=35&rft.epage=43&rft.pages=35-43&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2008.07.038&rft_dat=%3Cproquest_cross%3E66727424%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1505478692&rft_id=info:pmid/18809243&rfr_iscdi=true